ZA895867B - Infectious bursal disease virus - Google Patents

Infectious bursal disease virus

Info

Publication number
ZA895867B
ZA895867B ZA895867A ZA895867A ZA895867B ZA 895867 B ZA895867 B ZA 895867B ZA 895867 A ZA895867 A ZA 895867A ZA 895867 A ZA895867 A ZA 895867A ZA 895867 B ZA895867 B ZA 895867B
Authority
ZA
South Africa
Prior art keywords
bursal disease
infectious bursal
virus
disease virus
poultry
Prior art date
Application number
ZA895867A
Other languages
English (en)
Inventor
David B Snyder
B Snyder David
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Publication of ZA895867B publication Critical patent/ZA895867B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA895867A 1988-08-02 1989-08-01 Infectious bursal disease virus ZA895867B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/227,311 US5064646A (en) 1988-08-02 1988-08-02 Novel infectious bursal disease virus

Publications (1)

Publication Number Publication Date
ZA895867B true ZA895867B (en) 1990-05-30

Family

ID=22852607

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895867A ZA895867B (en) 1988-08-02 1989-08-01 Infectious bursal disease virus

Country Status (12)

Country Link
US (1) US5064646A (xx)
EP (1) EP0428596B1 (xx)
JP (1) JP3148214B2 (xx)
KR (1) KR900701314A (xx)
AT (1) ATE136788T1 (xx)
AU (1) AU631808B2 (xx)
CA (1) CA1340931C (xx)
DE (1) DE68926300T2 (xx)
FI (1) FI100383B (xx)
NZ (1) NZ230148A (xx)
WO (1) WO1990001336A1 (xx)
ZA (1) ZA895867B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
US5518724A (en) * 1988-08-02 1996-05-21 University Of Maryland Infectious bursal disease virus
US5632989A (en) * 1989-10-18 1997-05-27 University Of Maryland Attenuated, live vaccine for Delaware strain IBDV
NZ235474A (en) * 1989-10-18 1992-12-23 Univ Maryland Virus capable of inducing infectious bursal disease; assay and vaccine
US5595912A (en) * 1990-05-04 1997-01-21 University Of Maryland College Park Specific DNA and RNA sequences associated with US IBDV variants, vector carrying DNA sequences, host carrying cloned vector, deduced amino acid sequences, vaccine and method of vaccination
IL103939A (en) * 1992-12-01 1996-09-12 Abic Ltd An anti-DBI vaccine in birds containing attenuated live DBI virus
DE69824039T2 (de) 1997-12-08 2005-08-18 Lexigen Pharmaceuticals Corp., Lexington Heterodimäre fusionsproteine zur verwendung für gezielte immuntherapie und allgemeine immunerregung
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
WO2001058957A2 (en) 2000-02-11 2001-08-16 Lexigen Pharmaceuticals Corp. Enhancing the circulating half-life of antibody-based fusion proteins
MXPA03008031A (es) 2001-03-07 2003-12-04 Merck Patent Gmbh Tecnologia de expresion para proteinas que contienen porcion de anticuerpo isotipo hibrida.
US6992174B2 (en) 2001-03-30 2006-01-31 Emd Lexigen Research Center Corp. Reducing the immunogenicity of fusion proteins
CN100503639C (zh) 2001-05-03 2009-06-24 默克专利有限公司 重组肿瘤特异性抗体及其应用
WO2003048334A2 (en) 2001-12-04 2003-06-12 Merck Patent Gmbh Immunocytokines with modulated selectivity
US20040146530A1 (en) * 2002-01-30 2004-07-29 Sharma Jagdev M Avian vaccine effective against infectious bursal disease virus
ATE471946T1 (de) 2002-12-17 2010-07-15 Merck Patent Gmbh Humanisierter antikörper (h14.18) des maus antikörpers 14.18, der gd2 bindet und seine fusion mit il-2
WO2005049077A2 (en) * 2003-11-17 2005-06-02 Regents Of The University Of Minnesota Avian vaccine effective against infectious bursal disease virus
JP2008502317A (ja) 2003-12-30 2008-01-31 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング Ｉｌ−７融合タンパク質
AU2005206277B2 (en) 2004-01-22 2011-06-23 Merck Patent Gmbh Anti-cancer antibodies with reduced complement fixation
US7670595B2 (en) 2004-06-28 2010-03-02 Merck Patent Gmbh Fc-interferon-beta fusion proteins
CN100360662C (zh) * 2004-09-27 2008-01-09 长江大学 一种传染性法氏囊病基因工程亚单位疫苗的制备方法和应用
US7244432B2 (en) * 2004-12-08 2007-07-17 University Of Maryland Biotechnology Institute Infectious bursal disease virus (IBDV) variant from Georgia
ATE555125T1 (de) 2005-12-30 2012-05-15 Merck Patent Gmbh Interleukin-12p40-varianten mit verbesserter stabilität
ATE509954T1 (de) 2005-12-30 2011-06-15 Merck Patent Gmbh Anti-cd19-antikörper mit reduzierter immunogenität
EP2421896A1 (en) 2009-04-22 2012-02-29 Merck Patent GmbH Antibody fusion proteins with modified fcrn binding sites

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines

Also Published As

Publication number Publication date
AU631808B2 (en) 1992-12-10
EP0428596A4 (en) 1991-09-04
CA1340931C (en) 2000-03-21
WO1990001336A1 (en) 1990-02-22
KR900701314A (ko) 1990-12-01
FI910497A0 (fi) 1991-02-01
EP0428596A1 (en) 1991-05-29
DE68926300D1 (de) 1996-05-23
JPH04503153A (ja) 1992-06-11
EP0428596B1 (en) 1996-04-17
US5064646A (en) 1991-11-12
AU4055989A (en) 1990-03-05
FI100383B (fi) 1997-11-28
NZ230148A (en) 1993-01-27
JP3148214B2 (ja) 2001-03-19
DE68926300T2 (de) 1996-10-31
ATE136788T1 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
ZA895867B (en) Infectious bursal disease virus
CA2143823A1 (en) Retro-, inverso - and retro-inverso synthetic peptide analogues
NZ219113A (en) Hiv peptide containing epitope of the env protein
PT101052A (pt) Proteinas hibridas uteis na preparacao de vacinas
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
DE69111801D1 (de) Vakzin gegen hepatitis b.
Jemmerson et al. Mapping antigenic sites on proteins: Implications for the design of synthetic vaccines.
DE3854591D1 (de) Impfstoffe, deren charakteristischer Epitop in einem Picornavirusprotein, insbesondere Poliovirus, inkorporiert ist.
ES2087111T3 (es) Vacuna sintetica para la induccion especifica de linfocitos t citotoxicos.
ZA908260B (en) Infectious bursal disease virus
ZA856655B (en) Cross-reactive and protective epitopes of circumsporozoite proteins
DE69231495D1 (de) Neue cocain-derivate und protein- und polypeptid-cocain-derivate, konjugate und markierte verbindungen
EP0551308A4 (en) Novel peptide antigens and immunoassays, test kits and vaccines using the same
SE7910089L (sv) Vacciner
FI972658A (fi) Menetelmä rokotteen valmistamiseksi siipikarjan tarttuvaa bursaalitautia vastaan
DK0524421T3 (da) Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse
GB2314560A (en) Synthetic peptides of m. gallisepticum, antibodies thereto, their preparations and use
Erdei et al. Use of the ELISA-test for the serological screening for Aujeszky's virus infection in large-scale swine stocks.
FI950253A0 (fi) Fimbria-antigeenejä, -vasta-aineita, -osoitusmenetFimbria-antigeenejä, -vasta-aineita, -osoitusmenetelmiä ja -rokotteita elmiä ja -rokotteita